Laurent Dolle

Title: The Innovative Contributions of Laurent Dolle

Introduction

Laurent Dolle is a notable inventor based in Villeneuve d'Ascq, France. He has made significant contributions to the field of medical diagnostics, particularly in the area of breast cancer detection. His innovative approach has the potential to improve early diagnosis and therapeutic follow-up for patients.

Latest Patents

Laurent Dolle holds a patent for a method for NGF assay for in vitro diagnosis of breast cancer. This invention focuses on determining the presence of nerve growth factor (NGF) in biological samples from patients suspected of having breast cancer. The method is applicable for early diagnosis, screening, therapeutic follow-up, prognosis, and relapse diagnosis. Additionally, the invention includes the use of an NGF binding partner or inhibitor for preparing medicinal products aimed at blocking tumor proliferation and dissemination in breast cancer patients. He has 1 patent to his name.

Career Highlights

Throughout his career, Laurent Dolle has worked with prominent organizations such as bioMérieux, Inc. and Université des Sciences et Technologies de Lille. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical technology.

Collaborations

Laurent Dolle has collaborated with notable colleagues, including Eric Adriaenssens and Geneviève Choquet-Kastylevsky. These partnerships have further enhanced his research and development efforts in the medical diagnostics arena.

Conclusion

Laurent Dolle's innovative work in breast cancer diagnostics exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for improved patient outcomes and advancing the science of early detection.